Pasithea Therapeutics (KTTA) Stock Chart & Stock Price History $3.80 0.00 (0.00%) (As of 11/1/2024 ET) Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Pasithea Therapeutics Stock Price Performance5 Day Performance+2.98%1 Month Performance-22.61%3 Month Performance-22.45%6 Month Performance-45.09%Year-To-Date Performance-48.65%1 Year Performance-40.63% Receive KTTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Crypto 101 MediaCrypto Crash Ahead? (27 Experts Weigh In)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you!Click here to reserve your spot at the emergency crypto summit now. KTTA Stock Chart for Saturday, November, 2, 2024 KTTA Chart by TradingView Pasithea Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/01/2024$3.80$3.80$3.80$3.6321,327 shs$3.95 million10/31/2024$3.95$3.80-3.80%$4.01$3.6614,436 shs$3.97 million10/30/2024$3.92$3.95+0.77%$4.05$3.7013,329 shs$4.12 million10/29/2024$3.69$3.92+6.23%$4.05$3.6816,049 shs$4.09 million10/28/2024$3.70$3.69-0.27%$3.99$3.6950,439 shs$3.85 million10/25/2024$4.04$3.70-8.42%$4.05$3.4035,040 shs$3.85 million Get the Latest News and Ratings for KTTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/24/2024$4.16$4.04-2.88%$4.26$3.8531,137 shs$4.21 million10/23/2024$4.23$4.16-1.65%$4.32$4.1516,894 shs$4.34 million10/22/2024$4.39$4.23-3.64%$4.39$4.2015,490 shs$4.41 million10/21/2024$4.32$4.39+1.62%$4.48$4.2225,439 shs$4.58 million10/18/2024$3.99$4.32+8.27%$4.57$4.0035,517 shs$4.51 million10/17/2024$3.96$3.99+0.76%$4.21$3.9824,369 shs$4.16 million10/16/2024$3.95$3.96+0.25%$4.15$3.939,625 shs$4.13 million10/15/2024$4.73$3.95-16.49%$4.59$3.9596,679 shs$4.12 million10/14/2024$4.78$4.73-1.05%$4.73$4.558,605 shs$4.93 million10/11/2024$4.83$4.78-1.04%$4.78$4.603,718 shs$4.99 million10/10/2024$4.87$4.83-0.82%$4.87$4.6025,928 shs$5.04 million10/09/2024$4.71$4.87+3.40%$5.00$4.669,222 shs$5.08 million10/08/2024$5.22$4.71-9.77%$5.06$4.6211,880 shs$4.91 million10/07/2024$5.34$5.22-2.25%$5.45$5.0320,197 shs$5.44 million10/04/2024$5.23$5.34+2.10%$5.45$5.0925,934 shs$5.57 million10/03/2024$4.91$5.23+6.52%$5.30$4.8143,167 shs$5.46 million10/02/2024$4.73$4.91+3.81%$4.96$4.7728,130 shs$5.12 million10/01/2024$5.42$4.73-12.73%$5.36$4.6087,258 shs$4.93 million09/30/2024$6.09$5.42-11.00%$6.07$5.31228,677 shs$5.65 million09/27/2024$5.85$6.09+4.10%$6.15$5.31784,909 shs$6.35 million09/26/2024$3.85$5.85+52.15%$7.50$5.3556.70 million shs$6.10 million09/25/2024$3.96$3.85-2.90%$4.11$3.8020,759 shs$4.01 million09/24/2024$4.10$3.96-3.41%$4.32$3.8490,607 shs$4.13 million09/23/2024$4.42$4.10-7.24%$4.70$4.107,794 shs$4.28 million09/20/2024$4.80$4.42-7.92%$4.80$4.429,262 shs$4.61 million09/19/2024$5.80$4.80-17.24%$6.30$4.6265,877 shs$5.01 million09/18/2024$4.61$5.80+25.82%$6.10$4.3599,201 shs$6.05 million09/17/2024$3.92$4.61+17.60%$4.61$3.8520,676 shs$4.81 million09/16/2024$3.87$3.92+1.29%$3.98$3.872,062 shs$4.09 million09/13/2024$3.95$3.87-1.90%$3.92$3.853,594 shs$4.03 million09/12/2024$3.86$3.95+2.20%$3.96$3.8011,042 shs$4.12 million09/11/2024$3.89$3.86-0.77%$3.90$3.861,994 shs$4.03 million09/10/2024$4.25$3.89-8.47%$4.30$3.6117,874 shs$4.05 million09/09/2024$4.19$4.25+1.43%$4.65$4.0516,577 shs$4.42 millionWe recommended Nvidia in 2016, now we’re recommending this… (Ad)The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry.09/06/2024$4.28$4.19-2.10%$4.36$4.156,346 shs$4.37 million09/05/2024$4.44$4.28-3.60%$4.71$4.1937,653 shs$4.46 million09/04/2024$4.85$4.44-8.45%$4.80$4.3636,583 shs$4.63 million09/03/2024$4.55$4.85+6.59%$4.91$4.568,622 shs$5.06 million09/02/2024$4.55$4.55-0.03%$4.55$4.441,400 shs$4.75 million08/30/2024$4.57$4.55-0.44%$4.55$4.441,442 shs$4.75 million08/29/2024$4.56$4.57+0.22%$4.71$4.432,064 shs$4.77 million08/28/2024$4.61$4.56-1.08%$4.79$4.463,407 shs$4.76 million08/27/2024$4.60$4.61+0.22%$4.77$4.61389 shs$4.81 million08/26/2024$4.65$4.60-1.08%$4.70$4.502,822 shs$4.80 million08/23/2024$4.70$4.65-1.06%$5.44$4.5076,709 shs$4.85 million08/22/2024$4.78$4.70-1.67%$4.79$4.5521,578 shs$4.90 million08/21/2024$4.60$4.78+3.91%$4.78$4.562,249 shs$4.99 million08/20/2024$4.66$4.60-1.23%$4.80$4.601,942 shs$4.80 million08/19/2024$4.65$4.66+0.18%$4.80$4.6014,524 shs$4.86 million08/16/2024$4.59$4.65+1.31%$4.83$4.515,215 shs$4.85 million08/15/2024$4.56$4.59+0.66%$4.84$4.552,605 shs$4.79 million08/14/2024$4.83$4.56-5.59%$4.90$4.5127,397 shs$4.76 million08/13/2024$4.80$4.83+0.63%$4.83$4.701,786 shs$5.04 million08/12/2024$4.85$4.80-1.03%$4.81$4.673,943 shs$5.01 million08/09/2024$4.85$4.85$5.06$4.759,869 shs$5.06 million08/08/2024$4.75$4.85+2.11%$5.00$4.40107,006 shs$5.06 million08/07/2024$5.04$4.75-5.75%$5.36$4.4269,074 shs$4.95 million08/06/2024$6.25$5.04-19.36%$5.80$4.9661,190 shs$5.26 million08/05/2024$5.00$6.25+25.00%$6.25$4.96105,934 shs$6.52 million08/02/2024$5.01$4.90-2.20%$5.26$4.8515,115 shs$5.10 million08/01/2024$5.25$5.01-4.57%$5.50$5.0020,571 shs$5.21 million Related Companies Chemomab Therapeutics Stock Price Chart Minerva Neurosciences Stock Price Chart Akari Therapeutics Stock Price Chart Synlogic Stock Price Chart Biora Therapeutics Stock Price Chart Indaptus Therapeutics Stock Price Chart Unicycive Therapeutics Stock Price Chart Talphera Stock Price Chart PharmaCyte Biotech Stock Price Chart Sensei Biotherapeutics Stock Price Chart Receive KTTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Pasithea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:KTTA) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredThe Final FrontierAnd a lot of powerful investors would rather this exposé never saw the light of day. I suspect they’ll attempt...Porter & Company | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pasithea Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pasithea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KTTA Stock Alerts